Institutional and Fund Ownership - Buyers
Major holders that have opened new positions in PharmaCyte Biotech, Inc. include Raymond James Financial Inc, and Koesten, Hirschmann & Crabtree, INC. .
This page shows changes in the ownership structure by listing institutions, funds, and major shareholders that have increased their holdings or opened new positions in the last reporting period. Green rows indicate new positions. Click the link icon to see the full transaction history.
Upgradeto unlock premium data.
| File Date | Source | Investor | Type | Avg Price (Est) |
Shares | Δ Shares (%) |
Reported Value ($1000) |
Δ Value (%) |
Port Alloc (%) |
|
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-15 | 13F | Koesten, Hirschmann & Crabtree, INC. | 1 | 0 | ||||||
| 2025-08-13 | 13F | Renaissance Technologies Llc | 49,800 | 0.61 | 54 | -11.48 | ||||
| 2025-08-14 | 13F | Raymond James Financial Inc | 44 | 0 | ||||||
| 2025-08-14 | 13F | Susquehanna International Group, Llp | 27,606 | 49.98 | 30 | 30.43 | ||||
| 2025-07-24 | NP | FSMAX - Fidelity Extended Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 41,999 | 2.76 | 44 | -40.28 | ||||
| 2025-08-12 | 13F | Proequities, Inc. | Put | 0 | 0 | |||||
| 2025-08-14 | 13F | UBS Group AG | 22,592 | 89.59 | 25 | 71.43 | ||||
| 2025-09-04 | 13F/A | Advisor Group Holdings, Inc. | 305 | 2,950.00 | 0 | |||||
| 2025-08-12 | 13F | Proequities, Inc. | 0 | 0 | ||||||
| 2025-08-14 | 13F | Schonfeld Strategic Advisors LLC | 26,200 | 2.75 | 29 | -9.68 | ||||
| 2025-08-14 | 13F | Bank Of America Corp /de/ | 542 | 642.47 | 1 |
